Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Clive Holmes

Showing results (61-70 of 121) with videos related to

Pageof 13
Sort By:
The Journal of Nutrition, Health & Aging|June 28, 2025
Tooth loss, diet quality, and cognitive decline: A 15-year longitudinal studyLewis Winning, Danielle Logan, Claire T McEvoy, et al.
Gerontology|July 13, 2025
Low Hand Grip Strength Is Associated with Increased Risk of Cognitive Impairment in Older Men, Including Men with Probable Sarcopenic Obesity: Results from the Northern Ireland PRIME-COG CohortDominic N Farsi, Gareth J McKay, Gerry J Linden, et al.
Scientific Reports|February 29, 2020
Psychological stress, cognitive decline and the development of dementia in amnestic mild cognitive impairmentRebecca Sussams, Wolff Schlotz, Zoe Clough, et al.
The Journal of Pathology|November 29, 2014
Effect of active Aβ immunotherapy on neurons in human Alzheimer's diseaseClaire Paquet, Jay Amin, François Mouton-Liger, et al.
Lancet (London, England)|July 22, 2008
Long-term effects of Abeta42 immunisation in Alzheimer's disease: follow-up of a randomised, placebo-controlled phase I trialClive Holmes, Delphine Boche, David Wilkinson, et al.
The Journal of Pharmacy and Pharmacology|February 21, 2008
Pharmacological profile of an essential oil derived from Melissa officinalis with anti-agitation properties: focus on ligand-gated channelsSawsan Abuhamdah, Liping Huang, Mark S J Elliott, et al.
Journal of Neuropathology and Experimental Neurology|November 7, 2006
Abeta species removal after abeta42 immunizationJames A R Nicoll, Edward Barton, Delphine Boche, et al.
Plos One|March 11, 2016
Periodontitis and Cognitive Decline in Alzheimer's DiseaseMark Ide, Marina Harris, Annette Stevens, et al.
Neurology|May 3, 2015
Etanercept in Alzheimer disease: A randomized, placebo-controlled, double-blind, phase 2 trialJoseph Butchart, Laura Brook, Vivienne Hopkins, et al.
Translational Psychiatry|June 13, 2019
Correction: Alzheimer's disease polygenic risk score as a predictor of conversion from mild-cognitive impairmentSultan Chaudhury, Keeley J Brookes, Tulsi Patel, et al.
Pageof 13

Showing results (61-70 of 121) with videos related to

Sort By:
Pageof 13
The Journal of Nutrition, Health & Aging|June 28, 2025
Tooth loss, diet quality, and cognitive decline: A 15-year longitudinal studyLewis Winning, Danielle Logan, Claire T McEvoy, et al.
Gerontology|July 13, 2025
Low Hand Grip Strength Is Associated with Increased Risk of Cognitive Impairment in Older Men, Including Men with Probable Sarcopenic Obesity: Results from the Northern Ireland PRIME-COG CohortDominic N Farsi, Gareth J McKay, Gerry J Linden, et al.
Scientific Reports|February 29, 2020
Psychological stress, cognitive decline and the development of dementia in amnestic mild cognitive impairmentRebecca Sussams, Wolff Schlotz, Zoe Clough, et al.
The Journal of Pathology|November 29, 2014
Effect of active Aβ immunotherapy on neurons in human Alzheimer's diseaseClaire Paquet, Jay Amin, François Mouton-Liger, et al.
Lancet (London, England)|July 22, 2008
Long-term effects of Abeta42 immunisation in Alzheimer's disease: follow-up of a randomised, placebo-controlled phase I trialClive Holmes, Delphine Boche, David Wilkinson, et al.
The Journal of Pharmacy and Pharmacology|February 21, 2008
Pharmacological profile of an essential oil derived from Melissa officinalis with anti-agitation properties: focus on ligand-gated channelsSawsan Abuhamdah, Liping Huang, Mark S J Elliott, et al.
Journal of Neuropathology and Experimental Neurology|November 7, 2006
Abeta species removal after abeta42 immunizationJames A R Nicoll, Edward Barton, Delphine Boche, et al.
Plos One|March 11, 2016
Periodontitis and Cognitive Decline in Alzheimer's DiseaseMark Ide, Marina Harris, Annette Stevens, et al.
Neurology|May 3, 2015
Etanercept in Alzheimer disease: A randomized, placebo-controlled, double-blind, phase 2 trialJoseph Butchart, Laura Brook, Vivienne Hopkins, et al.
Translational Psychiatry|June 13, 2019
Correction: Alzheimer's disease polygenic risk score as a predictor of conversion from mild-cognitive impairmentSultan Chaudhury, Keeley J Brookes, Tulsi Patel, et al.
Pageof 13